









































Pa
ge

 
1



Pa
ge

 
36

American Journal of  Medical 
Science and Innovation (AJMSI) 

The Incidence of  Head and Neck Cancer in East Sudan
Mona Mahmoud Abasher1*, Amal Abdelhakam Sidahmed1, Asjad Abdelmoniem1, 

Hyffa Osman Mohamed Ahmed1

Volume 2 Issue 2, Year 2023
ISSN: 2836-8509 (Online)

DOI: https://doi.org/10.54536/ajmsi.v2i2.1746
https://journals.e-palli.com/home/index.php/ajmsi

Article Information ABSTRACT

Received: May 20, 2023

Accepted: July 08, 2023

Published: July 28, 2023

This review aims to provide an updated and detailed overview of  the incidence of  head 
and neck cancer in the eastern region of  Sudan, focusing on studies conducted between 
2018 and 2023. It aims to shed light on changes in incidence rates, emerging risk factors, 
advancements in diagnostic techniques, treatment modalities, and preventive strategies. 
Accurate knowledge of  the latest trends and developments in head and neck cancer incidence 
is essential for effective public health planning and intervention. One significant aspect that 
the review highlights is the limited number of  head and neck surgeons in East Sudan. It 
emphasizes the need for specialized training in staging malignancies using head and neck 
anatomy, as this information is vital for determining appropriate treatment approaches. With 
a shortage of  trained professionals, it becomes even more critical to enhance the anatomic 
understanding and staging capabilities in order to improve patient outcomes and optimize 
treatment plans. The review underscores the urgency of  addressing this gap in healthcare 
infrastructure. By increasing the number of  head and neck surgeons in East Sudan and 
providing them with the necessary training, the region can improve its capacity to accurately 
stage head and neck cancers, leading to more effective treatment decisions and improved 
patient care. This review provides a comprehensive resource for understanding the current 
landscape of  head and neck cancer incidence in the eastern region of  Sudan. It addresses 
recent trends, emerging risk factors, and the need for improved anatomic understanding 
and staging capabilities. The findings can guide policymakers, healthcare providers, and 
researchers in implementing targeted strategies to reduce the burden of  head and neck 
cancer in East Sudan and improve patient outcomes.

Keywords
Head and Neck Cancer, East 
of  Sudan, Incidence, Risk 
Factors, Diagnosis, Treatment, 
Prevention

1 Port Sudan Oncology Centre P.O.C, Sudan
* Corresponding author’s e-mail: monaabasherahmed@gmail.com

INTRODUCTION
The sixth most prevalent type of  cancer worldwide is head 
and neck squamous cell carcinoma (HNSCC) (Johnson et 
al., 2020). HNC was the second most prevalent malignancy 
recorded in men, after cancer of  the prostate, and in 
women, behind cancers of  the breast, cervix uteri, eye, 
and oesophagus, between 2018 and 2023, according to 
the Nairobi cancer registry (Joko‐Fru et al., 2020). Cancer-
related morbidity and mortality are prevalent in Sudan East 
and are rising quickly. 
While the number of  yearly fatalities in the area from HIV, 
TB, and malaria is progressively dropping, the number of  
deaths from cancer is expected to rise by 85% between 
2008 and 2030 (Ibrahim et al., 2021). These forecasts are 
primarily based on predicted population increase and aging 
and assume static age-specific incidence rates. However, 
population-based cancer registries show rising cancer 
incidence, perhaps due to HIV and the westernisation of  
lifestyles (Msyamboza et al., 2012). Traditional HNSCC 
risk factors include drinking alcohol, smoking, and 
using tobacco products for chewing; ethnicity, genetic 
background, regional origin, and dietary condition are 
other risk factors. Human papillomavirus (HPV) infection 
is a newly identified risk factor for HNSCC, defining a new 
subtype of  tumour distinct from HPV-negative tumours 
(Sabatini & Chiocca, 2020). The International Agency for 
Research on Cancer has identified HPV as an HNSCC 
carcinogen (Papillomaviruses, 2011).  In the upper 

aerodigestive tract, which includes the mouth (oral cavity), 
lip, paranasal sinuses, nasal cavity, larynx, and pharynx, 
a variety of  primary cancers arise. These are collectively 
called head and neck cancers (Pai & Westra, 2009). HNC 
is the sixth most prevalent cancer globally, with around 
600,000 new cases each year with unacceptable fatality 
rates, particularly in underdeveloped nations, approaching 
300,000 deaths annually (Jou & Hess, 2017). Head and 
neck squamous cell carcinoma (HNSCC), a subtype of  
HNC that develops from the mucosal lining epithelium 
of  the upper aerodigestive tract, accounts for more than 
90% of  all cases of  HNC  (Chaturvedi et al., 2013). This 
means that estimates of  the future cancer burden in the 
area may be greatly exaggerated. In high-income nations, 
cancer survivorship has increased thanks to earlier cancer 
detection through screening, more knowledge of  the 
biology and aetiology of  tumours, better treatments, and 
supportive care. The larynx, other pharynx, nasopharynx, 
oral cavity, and lip sites comprise the sixth most prevalent 
malignancy (Wright, 2023). Based on the intricate 
anatomy and physiology of  the head and neck area, upper 
aerodigestive tract malignancies are staged by site and sub-
site per the American Joint Commission on Cancer (AJCC) 
staging manual (Allen et al., 2017). The AJCC has identified 
the aerodigestive anatomic locations of  the larynx, 
hypopharynx, oral cavity, nasopharynx, and sinonasal. 
Squamous cell carcinoma is the most prevalent histology 
across all head and neck sites (Giannis et al., 2021). 



Pa
ge

 
37

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 2(2) 36-43, 2023

The head and neck are depicted. The mucosal surface of  
the lips, the front two-thirds of  the tongue, the buccal 
mucosa, the retromolar trigone, and the hard palate 
are all parts of  the oral cavity. The soft palate, palatine 
tonsils, and tongue base are all located in the oropharynx, 
directly behind the oral cavity. The nasal cavity, clivus, 
soft palate, and sphenoid surround the superiorly situated 
nasopharynx. The supraglottis, glottis, and subglottis are 
parts of  the larynx. The piriform sinus, postcricoid gap, 
and posterior pharyngeal wall are the subsites of  the 
hypopharynx, located immediately posterior to the larynx. 
The paranasal sinuses and nasal cavities are additional 
head and neck locations.

LITERATURE REVIEW
Particularly in Sudan’s east, head and neck cancer is 
a frequent and alarming problem. An updated and 
thorough grasp of  the incidence, risk factors, diagnostic 
procedures, treatment modalities, and preventive measures 
particular to this area is what this literature review tries to 
deliver. This evaluation addresses significant deficiencies 
in the healthcare infrastructure while also shedding 
light on current trends and changes by emphasising 
investigations carried out between 2018 and 2023. The 
few head and neck surgeons in East Sudan is a key issue 
that is mentioned in this review. The essential need for 
specialised training in staging malignancies utilising head 
and neck anatomy is highlighted by the dearth of  qualified 
experts. Accurate treatment strategies can be chosen, 
ultimately improving patient outcomes, by improving 
anatomical understanding and staging capabilities. To 
meet the increasing demands of  head and neck cancer 
management, it is critical to address this gap in the 
healthcare infrastructure. Examining new risk factors is 
crucial for understanding the state of  head and neck cancer 
in East Sudan. Infection with the human papillomavirus 
(HPV) and immunosuppression have both been noted 
as significant risk factors for the development of  head 

and neck cancer in recent research. These discoveries 
deepen our comprehension of  the local aetiology of  
the disease and call for specialised preventive measures. 
Modernizations in diagnostic methods and therapeutic 
approaches are essential for efficient management. This 
study emphasises the advancements made in fields 
including laboratory research, imaging modalities (CT, 
MRI), and biopsies. Early detection, appropriate staging, 
and individualised treatment planning have all improved 
thanks to these developments. East Sudan’s healthcare 
personnel can improve patient care by utilising these 
diagnostic tools.
Head and neck cancer prevention and early detection 
are crucial in reducing the burden. East Sudan has 
implemented public health interventions, tobacco 
control programs, HPV vaccination, and awareness 
campaigns to educate the population, promote healthy 
behaviors, and encourage regular screenings. Evaluating 
these strategies and addressing region-specific challenges 
is vital for tailored prevention and management 
approaches. Understanding regional challenges, such as 
limited resources, infrastructure, cultural considerations, 
and socioeconomic disparities, is essential for designing 
effective strategies. This review can guide future research, 
prevention programs, and treatment approaches, 
ultimately leading to improved outcomes and reduced 
incidence of  head and neck cancer in East Sudan.

Immunosuppression
Immunosuppressed people are more likely to acquire 
mouth cancer. Patients with human immunodeficiency 
virus (HIV) are prone to Kaposi’s sarcoma and 
lymphomas but not to OSCC. Lip tumours have been 
linked to immunosuppressed organ transplant patients, 
and the possible cause was suggested to be greater 
exposure to solar radiation and other risk factors, 
including smoking (Ritchie & Singanayagam, 2020). The 
investigations did not, however, provide evidence linking 
immunosuppression directly to the emergence of  lip 
cancer (Van Leeuwen et al., 2009).

Risk Factors
Identifying risk factors is crucial for understanding 
the aetiology of  head and neck cancer and developing 
targeted preventive strategies. This section reviews the 
recent literature on risk factors associated with head and 
neck cancer in the East of  Sudan (Almarzooqi et al., 2023), 
including tobacco and alcohol use, betel quid chewing, 
HPV infection, dietary habits, and genetic predisposition 
(Mosalleum, 2014). The emphasis is on the evolving 
understanding of  these risk factors and their impact on 
the local population. The most frequent risk factors for 
people with head and neck squamous cell carcinoma 
(HNSCC) historically have been cigarette and alcohol use 
(Zhou et al., 2020).
About 80% of  HNSCC patients were associated with 
an elevated risk due to cigarette smoking or alcohol 
consumption, which is common in those with a lengthy 

Figure 1: Shows the flow of  head and neck cancer in the 
human body



Pa
ge

 
38

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 2(2) 36-43, 2023

history of  both behaviours (Cherry et al., 2018). The 
primary cause of  many types of  cancer, including 
HNSCC, has been identified as the carcinogenic influence 
of  tobacco use. All tobacco products, including water 
pipes and electronic cigarettes, have negative, long-term 
impacts on health, especially in the head and neck region 
(Saunders et al., 2022). 

Histological Types and Distribution
Head and neck cancers encompass various histological 
types with distinct characteristics and treatment 
implications (Chiesa-Estomba et al., 2021). This section 
provides an updated overview of  the histological types and 
their distribution in the East of  Sudan. The focus is on the 
prevalence of  specific subtypes and any changes observed 
during the review period (Bhattacharjee et al., 2006).

Histological Types
Head and neck cancers refer to a group of  cancers that can 
occur in various regions of  the head and neck, including 
the oral cavity, pharynx, larynx, and others (Doobaree 
et al., 2009). These cancers are classified based on their 
histological types, which means the specific cell types and 
tissue characteristics involved in the cancer formation. 
Histological types help determine the behaviour of  the 
cancer, its response to treatment, and prognosis (da Cruz 
Perez et al., 2006).

Distinct Characteristics and Treatment Implications
Each histological type of  head and neck cancer has distinct 
characteristics, such as the cell type involved, the pattern 
of  growth, and the molecular features (Perri et al., 2020). 
These characteristics can influence the behaviour of  the 
cancer and its response to different treatment modalities, 
such as surgery, radiation therapy, or chemotherapy. 
Therefore, understanding the histological types is 
important for tailoring each patient’s most appropriate 
treatment approach (De Carvalho et al., 2012).

Overview of  Histological Types
It provides an updated overview of  the histological types in 
the East of  Sudan. This suggests that there may have been 

Figure 2: Summary of  potential risk factors that cause the generation of  HNSCC

previous studies or data that described the distribution of  
histological types, and this paragraph aims to present a 
more recent understanding based on new information or 
research.

Distinct Characteristics and Treatment Implications
The focus is on the prevalence of  specific subtypes within 
the histological types of  head and neck cancers. Subtypes 
refer to different variations or subcategories within a 
broader histological type (Gebril et al., 2022). For example, 
within the category of  squamous cell carcinoma (a 
common histological type of  head and neck cancer), there 
may be subtypes like basaloid squamous cell carcinoma or 
papillary squamous cell carcinoma. This paragraph aims to 
provide information about the prevalence of  these specific 
subtypes in the East of  Sudan (Blumberg et al., 2015).

Changes Observed During the Review Period
Any changes observed during the review period will be 
discussed. This indicates that the researchers or authors of  
the paragraph have conducted a review or analysis of  data 
from a specific period. They likely compared this data to 
previous studies or data to identify any shifts or alterations 
in the prevalence or distribution of  histological types or 
specific subtypes of  head and neck cancers in the East of  
Sudan.

Advances in Diagnosis
Rapid and accurate diagnosis is crucial for optimal head 
and neck cancer management. This section discusses the 
recent advancements in diagnostic techniques, including 
biopsy, imaging modalities (CT, MRI), and laboratory 
investigations (Grégoire et al., 2015). The focus is on how 
these advancements have improved early detection, staging, 
and treatment planning in the East of  Sudan.
Rapid and Accurate Diagnosis: A prompt and accurate 
diagnosis is crucial for optimal managing head and neck 
cancer. Early detection and accurate diagnosis allow for 
the timely initiation of  appropriate treatment strategies, 
which can significantly impact patient outcomes (Harris et 
al., 2010).



Pa
ge

 
39

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 2(2) 36-43, 2023

Advancements in Diagnostic Techniques
Recent advancements have been made in head and neck 
cancer diagnostic techniques. These advancements refer 
to improvements or innovations in the methods used to 
diagnose and evaluate the disease. The following techniques 
are specifically mentioned:

Biopsy
Biopsy is a procedure in which a small tissue sample is taken 
from the affected area and examined under a microscope 
to determine if  cancer is present. Recent advancements 
in biopsy techniques may include minimally invasive 
procedures or more precise sampling methods to enhance 
diagnostic accuracy (Kong & Birkeland, 2021).

Imaging Modalities
The paragraph mentions CT (Computed Tomography) and 
MRI (Magnetic Resonance Imaging) as imaging modalities 
to diagnose head and neck cancer. These imaging techniques 
provide detailed images of  the affected areas, allowing 
healthcare professionals to visualise the tumour’s location, 
size, and extent of  spread (Liao et al., 2012). Advancements 
in CT and MRI technology may include higher-resolution 
imaging, improved contrast agents, or specialised protocols 
for specific head and neck cancer types.

Laboratory Investigations
Laboratory investigations encompass tests performed on 
blood, saliva, or other samples to detect specific markers or 
abnormalities associated with head and neck cancer. Recent 
advancements in laboratory investigations may involve the 
development of  new biomarkers or more sensitive and 
specific testing methods that aid in diagnosing, staging, or 
monitoring the disease (Peter et al., 2013).

Improved Early Detection, Staging, and Treatment 
Planning
These advancements in diagnostic techniques have 
improved early detection, staging, and treatment planning, 
specifically in the East of  Sudan. Early detection refers 
to identifying the cancer early when it is more likely to 
be treated successfully. Accurate staging helps determine 
the extent of  the disease and guides treatment decisions. 
Advanced diagnostic techniques enable healthcare 
professionals in the East of  Sudan to identify head and 
neck cancer earlier, accurately stage the disease, and 
develop personalised treatment plans tailored to each 
patient’s condition (Scott et al., 2008).

METHODOLOGY
To indicate the incidence of  head and neck cancer in east 
Sudan in different age groups, several recent studies, review 
articles, prospective studies, cross-sectional studies, and 
literature reviews, all published and peer-reviewed, were 
searched and considered. Data was gathered from different 
search engines and databases such as; Google Scholar, 
Scopus, PubMed, Elsevier, Cochrane, Sage, Medline and 
Web of  Science.

Numerous studies were selected from 2018-2023, using the 
keywords “Head and Neck Carcinomas”, “HNSCC”, “East 
of  Sudan”, “Risk Factors”, “Incidence”, “Advancements”, 
‘Future challenges”, “Diagnosis”, “Treatment”.’ The full 
texts of  the retrieved articles were made accessible.
This article is a review. Thus not all information on the 
incidence of  head and neck cancer has been provided 
are contained in this. We have included observational 
studies and all significant, pertinent big trials to highlight 
the overall conclusions. Although we tried to incorporate 
the largest and most pertinent research, it is important to 
remember that the tiny, hopeful observational studies were 
likely chosen due to publication bias.

DISCUSSION
Treatment Modalities
Effective management of  head and neck cancer requires a 
multidisciplinary approach. This section reviews the recent 
advancements in treatment modalities, including surgery, 
radiation therapy, chemotherapy, targeted therapies, and 
immunotherapy, in the East of  Sudan. The focus is on new 
treatment options, outcomes, and challenges in resource-
limited settings (Syrigos et al., 2009).

Multidisciplinary Approach
Effective management of  head and neck cancer requires 
a multidisciplinary approach. This means that various 
healthcare professionals from different specialities, such as 
surgeons, radiation oncologists, medical oncologists, and 
others, collaborate to develop comprehensive treatment 
plans and provide optimal patient care.
Recent Advancements in Treatment Modalities: Recent 
advancements have been made in treatment modalities 
for head and neck cancer in the East of  Sudan. These 
advancements refer to new or improved methods of  
treatment that have emerged in recent times (Galbiatti et al., 
2013). The following treatment modalities are specifically 
mentioned:

Surgery
Surgery involves the removal of  the tumour and nearby 
affected tissues. Advancements in surgical techniques 
may include minimally invasive procedures, improved 
reconstructive options, or more precise surgical navigation 
systems, which can help maximise tumour removal while 
minimising damage to healthy tissues (Mody, 2021).

Radiation Therapy
Radiation therapy uses high-energy radiation to kill cancer 
cells or shrink tumours. Recent advancements in radiation 
therapy may include more precise and targeted radiation 
delivery techniques, such as intensity-modulated radiation 
therapy (IMRT) or stereotactic radiosurgery (SRS), (Lalla, 
R. V., Brennan, 2019) which can improve treatment 
outcomes while minimising side effects.

Chemotherapy 
Chemotherapy involves using drugs to kill cancer cells or 



Pa
ge

 
40

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 2(2) 36-43, 2023

prevent their growth. Advancements in chemotherapy may 
include the development of  new drugs or more targeted 
chemotherapy regimens that specifically target cancer cells 
while minimising damage to normal cells.

Targeted Therapies
Targeted therapies are drugs that specifically target certain 
molecular or genetic abnormalities in cancer cells. These 
therapies aim to disrupt specific pathways or proteins that 
promote cancer growth (Alsahafi, E., Begg, K., Amelio, 
I., Raulf, N., Lucarelli, P., Sauter, T., & Tavassoli, M. 
(2019). Advancements in targeted therapies may include 
discovering new targets or developing more effective 
drugs that can inhibit these targets, leading to improved 
treatment outcomes.

Immunotherapy
Immunotherapy is a treatment that harnesses the body’s 
immune system to fight cancer (Gavrielatou, N., Doumas, 
S., Economopoulou, 2021). Recent advancements in 
immunotherapy for head and neck cancer may include 
immune checkpoint inhibitors, therapeutic vaccines, or 
adoptive cell therapies, which can enhance the immune 
response against cancer cells and improve treatment 
outcomes.

New Treatment Options, Outcomes, and Challenges
The paragraph mentions the focus is on new treatment 
options, treatment outcomes, and challenges in resource-
limited settings (Starzyńska et al., 2022). This indicates that 
the authors or researchers have examined the introduction 
of  novel treatments, the impact of  these treatments on 
patient outcomes, and the specific challenges faced in 
implementing these advancements in a resource-limited 
setting like the East of  Sudan. Resource limitations may 
include factors such as the availability of  specialised 
equipment, financial constraints, or limited access to 
certain medications (Zaryouh et al., 2022).

Prevention and Screening Strategies
Prevention and early detection play a vital role in reducing 
the burden of  head and neck cancer. This section discusses 
recent efforts and strategies implemented in the East of  
Sudan for prevention and screening, including public 
health interventions, tobacco control programs, HPV 
vaccination, and public awareness campaigns. The focus 
is on the impact of  these strategies and any barriers to 
implementation (Hashim et al., 2019).

Prevention and Early Detection
Prevention and early detection are crucial in combating 
head and neck cancer. Prevention strategies aim to reduce 
the occurrence of  cancer by targeting risk factors, while 
early detection strategies focus on identifying cancer at an 
early stage when treatment outcomes are generally more 
favourable (Johnson, D. E., Burtness, 2020).

Recent Efforts and Strategies
In the East of  Sudan, recent initiatives and tactics have 

been put into practise to detect and prevent head and neck 
cancer. This shows that deliberate steps or activities have 
been done to address the disease’s impact in the area. They 
mention the following tactics:

Public Health Interventions
Public health interventions refer to targeted actions 
implemented at the population level to promote health 
and prevent diseases. In the context of  head and 
neck cancer, public health interventions may include 
educational campaigns, community outreach programs, 
or health promotion initiatives to raise awareness about 
risk factors, promote healthy behaviours, and encourage 
regular screenings (Mady, L. J., Kubik, M. W., Baddour, K., 
Snyderman, C. H., & Rowan, N. R. (2020).

Tobacco Control Programs
Tobacco use is a significant risk factor for head and neck 
cancer. Tobacco control programs aim to reduce tobacco 
consumption through various measures such as awareness 
campaigns, tobacco taxation, smoking cessation programs, 
and the implementation of  smoke-free policies in public 
places (Mody, M. D., Rocco, 2021). These programs can 
help decrease the incidence of  head and neck cancer by 
reducing tobacco-related exposures.

HPV Vaccination
The human papillomavirus (HPV) is a known risk factor 
for certain types of  head and neck cancer. HPV vaccination 
programs target the prevention of  HPV infection, primarily 
through vaccination of  adolescents (Turbeville, H. R., Toni, 
T. A., & Allen, C. (2022). HPV vaccination can significantly 
reduce the risk of  developing HPV-related head and neck 
cancer. Implementing HPV vaccination programs in the 
East of  Sudan can contribute to prevention efforts.

Public Awareness Campaigns
Public awareness campaigns aim to educate the general 
population about the signs and symptoms of  head and 
neck cancer, the importance of  early detection, and the 
availability of  screening services. These campaigns raise 
awareness, improve knowledge, and encourage individuals 
to seek timely medical evaluation, potentially leading to 
early diagnosis and treatment.

Impact of  Strategies and Barriers to Implementation
The paragraph mentions that the focus is on the impact of  
these strategies and any barriers to implementation. This 
indicates that the authors or researchers have evaluated the 
effectiveness of  the implemented strategies and assessed 
the challenges faced in carrying out these initiatives in the 
East of  Sudan. Barriers to implementation could include 
limited resources, cultural factors, access to healthcare 
services, or community engagement (Russell, 2015).

Future Directions and Challenges
This section highlights the future directions for research, 
prevention, and management of  head and neck cancer 
in the East of  Sudan. It discusses the challenges specific 



Pa
ge

 
41

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 2(2) 36-43, 2023

to the region and identifies areas that require further 
investigation and intervention (Mody, M. D., Rocco, 
2021). The aim is to provide insights into potential 
strategies to improve outcomes and reduce the incidence 
of  head and neck cancer.

Challenges Specific to the Region
There are challenges specific to the East of  Sudan 
regarding head and neck cancer. These challenges 
could include limited resources, infrastructure, access 
to healthcare services, cultural considerations, or 
socioeconomic disparities. Understanding and addressing 
these region-specific challenges are crucial for designing 
effective strategies to tackle head and neck cancer in the 
East of  Sudan.

Areas Requiring Further Investigation and Intervention
Certain areas require further investigation and 
intervention. This suggests that there are gaps in 
knowledge or areas that need more attention to improve 
the region’s prevention and management of  head and 
neck cancer. These areas could include understanding 
the specific risk factors prevalent in the population, 
evaluating the effectiveness of  current interventions, 
identifying new treatment options, studying the impact 
of  genetic or molecular factors, or exploring disparities in 
access to healthcare.

Insights and Potential Strategies
The aim is to provide insights into potential strategies 
to improve outcomes and reduce the incidence of  
head and neck cancer. This indicates that the authors 
or researchers aim to offer valuable information 
and recommendations to guide future efforts. These 
insights may include suggestions for targeted prevention 
programs, improvements in early detection methods, the 
development of  more accessible and affordable treatment 
options, or recommendations for policy changes to 
address the challenges faced in the region.

CONCLUSION
The incidence of  head and neck cancer in the East of  
Sudan continues to be a significant public health concern. 
This review provides an updated understanding of  the 
recent epidemiological trends, risk factors, diagnostic 
advances, treatment modalities, and preventive strategies 
specific to the region. By focusing on the recent 
developments and future directions, this review aims to 
contribute to the ongoing efforts to address head and 
neck cancer in the East of  Sudan. The review emphasises 
the importance of  a multidisciplinary approach in 
effectively managing this disease. It underscores the 
significance of  rapid and accurate diagnosis, enhanced 
by recent advancements in diagnostic techniques such 
as biopsy, imaging modalities (CT, MRI), and laboratory 
investigations. These advancements have improved the 
region’s early detection, staging, and treatment planning.

The review also emphasises recent advancements in 
treatment modalities, including surgery, radiation therapy, 
chemotherapy, targeted therapies, and immunotherapy. 
These advancements offer new options for patients in the 
East of  Sudan and have the potential to improve treatment 
outcomes. Furthermore, prevention and early detection 
strategies are vital in reducing the burden of  head and 
neck cancer. Efforts such as public health interventions, 
tobacco control programs, HPV vaccination, and public 
awareness campaigns have been implemented to address 
these aspects in the region. Highlights the challenges 
specific to the East of  Sudan, such as limited resources, 
infrastructure, access to healthcare services, and cultural 
considerations. These challenges necessitate further 
research, investigation, and intervention to develop 
tailored strategies that address the region’s unique needs. 
Identifying future directions for research, prevention, 
and management is crucial in guiding efforts to improve 
outcomes and reduce the incidence of  head and neck 
cancer in the East of  Sudan. 

Novelty of  Research
The study focuses on head and neck cancer incidence 
in the eastern region of  Sudan, focusing on the region’s 
unique characteristics and challenges. It provides an 
updated overview of  the landscape from 2018 to 
2023, identifying emerging risk factors, highlighting 
advancements in diagnostic techniques and treatment 
modalities, and emphasizing the need for specialized 
training in head and neck anatomy staging malignancies. 
The review emphasizes the need for improved healthcare 
infrastructure and addressing the gap in head and neck 
surgeons in the eastern region.

Contribution to Knowledge
The review provides an updated overview of  head and 
neck cancer incidence in the eastern region of  Sudan 
from 2018 to 2023, highlighting emerging risk factors like 
immunosuppression and HPV infection. It also discusses 
advancements in diagnostic techniques and treatment 
modalities, emphasizing the need for specialized 
training and healthcare infrastructure to improve early 
detection, staging, and personalized treatment planning. 
Addressing the gap in healthcare infrastructure is crucial 
for enhancing anatomic understanding and staging 
capabilities, ultimately leading to better patient outcomes.

Fulfillment of  Research Gap
The review provides a comprehensive resource on head 
and neck cancer incidence in the eastern region of  Sudan, 
incorporating recent studies and data. It addresses the 
need for targeted strategies, diagnostic techniques, and 
treatment modalities, guiding policymakers, healthcare 
providers, and researchers in implementing these 
interventions. The review also highlights challenges, 
such as limited resources and infrastructure, and offers 
recommendations for future research and intervention.



Pa
ge

 
42

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 2(2) 36-43, 2023

Acknowledgement
None

Conflict of  Interest
The authors declare no conflict of  interest.

Funding
The authors declare no financial support. 

REFERENCES 
Allen, P. J., Kuk, D., Fernandez-del Castillo, C., Basturk, 

O., Wolfgang, C. L., Cameron, J. L., Lillemoe, K. D., 
Ferrone, C. R., Morales-Oyarvide, V., & He, J. (2017). 
Multi-institutional validation study of  the American 
Joint Commission on Cancer changes for T and N 
staging in patients with pancreatic adenocarcinoma. 
Annals of  surgery, 265(1), 185. 

Almarzooqi, S., Hashim, M. J., Awwad, A., Sharma, C., 
Saraswathiamma, D., Albawardi, A., & Awwad Sr, A. 
(2023). Lower Prevalence of  Human Papillomavirus 
in Head and Neck Squamous Cell Carcinoma in 
Middle Eastern Population: Clinical Implications for 
Diagnosis and Prevention. Cureus, 15(2). 

Alsahafi, E., Begg, K., Amelio, I., Raulf, N., Lucarelli, P., 
Sauter, T., & Tavassoli, M. (2019). Clinical update on 
head and neck cancer: molecular biology and ongoing 
challenges. Cell death & disease, 10(8), 540.

Bhattacharjee, A., Chakraborty, A., & Purkaystha, P. 
(2006). Prevalence of  head and neck cancers in the 
north east—an institutional study. Indian Journal of  
Otolaryngology and head and neck surgery, 58, 15-19. 

Blumberg, J., Monjane, L., Prasad, M., Carrilho, C., & 
Judson, B. L. (2015). Investigation of  the presence 
of  HPV related oropharyngeal and oral tongue 
squamous cell carcinoma in Mozambique. Cancer 
epidemiology, 39(6), 1000-1005. 

Chaturvedi, A. K., Anderson, W. F., Lortet-Tieulent, J., 
Curado, M. P., Ferlay, J., Franceschi, S., Rosenberg, P. 
S., Bray, F., & Gillison, M. L. (2013). Worldwide trends 
in incidence rates for oral cavity and oropharyngeal 
cancers. Journal of  clinical oncology, 31(36), 4550. 

Cherry, K., Schwarz, R. A., Yang, E., Badaoui, H., 
Williams, M. D., Vigneswaran, N., Gillenwater, A. 
M., & Richards-Kortum, R. (2018). Noninvasive 
autofluorescence imaging for tracking and monitoring 
the progression of  oral premalignant lesions. Clinical 
and Translational Biophotonics.

Chiesa-Estomba, C. M., Lechien, J. R., Ayad, T., Calvo-
Henriquez, C., González-García, J. Á., Sistiaga-
Suarez, J. A., Dequanter, D., Fakhry, N., Melesse, G., 
& Piazza, C. (2021). Clinical and histopathological risk 
factors for distant metastasis in head and neck cancer 
patients. Acta Otorhinolaryngologica Italica, 41(1), 6. 

da Cruz Perez, D. E., de Abreu Alves, F., Nishimoto, 
I. N., De Almeida, O. P., & Kowalski, L. P. (2006). 
Prognostic factors in head and neck adenoid cystic 
carcinoma. Oral oncology, 42(2), 139-146. 

De Carvalho, A. C., Kowalski, L. P., Campos, A. H. J. F. 

M., Soares, F. A., Carvalho, A. L., & Vettore, A. L. 
(2012). Clinical significance of  molecular alterations 
in histologically negative surgical margins of  head and 
neck cancer patients. Oral oncology, 48(3), 240-248. 

Doobaree, I. U., Landis, S. H., Linklater, K. M., El-Hariry, 
I., Moller, H., & Tyczynski, J. (2009). Head and neck 
cancer in South East England between 1995–1999 
and 2000–2004: an estimation of  incidence and 
distribution by site, stage and histological type. Oral 
oncology, 45(9), 809-814. 

Gavrielatou, N., Doumas, S., Economopoulou, P., 
Foukas, P. G., & Psyrri, A. (2020). Biomarkers for 
immunotherapy response in head and neck cancer. 
Cancer treatment reviews, 84, 101977.

Galbiatti, A. L. S., Padovani-Junior, J. A., Maníglia, J. 
V., Rodrigues, C. D. S., Pavarino, É. C., & Goloni-
Bertollo, E. M. (2013). Head and neck cancer: 
causes, prevention and treatment. Brazilian journal of  
otorhinolaryngology, 79, 239-247. 

Gebril, M. A. B., Mukhtar, W. N. O., Elhassan, M. M. A., 
& Mahmoud, I. (2022). Incidence Characteristics and 
Histological Types of  Head and Neck Cancer among 
Adults in Central Sudan: A Retrospective Study. 
International Journal of  Environmental Research and Public 
Health, 19(21), 13814. 

Giannis, D., Cerullo, M., Moris, D., Shah, K. N., Herbert, 
G., Zani, S., Blazer 3rd, D. G., Allen, P. J., & Lidsky, 
M. E. (2021). Validation of  the 8th edition American 
Joint Commission on Cancer (AJCC) gallbladder 
cancer staging system: Prognostic discrimination and 
identification of  key predictive factors. Cancers, 13(3), 
547. 

Grégoire, V., Langendijk, J. A., & Nuyts, S. (2015). 
Advances in radiotherapy for head and neck cancer. 
Journal of  clinical oncology, 33(29), 3277-3284. 

Harris, A. T., Rennie, A., Waqar-Uddin, H., Wheatley, S. 
R., Ghosh, S. K., Martin-Hirsch, D. P., Fisher, S. E., 
High, A. S., Kirkham, J., & Upile, T. (2010). Raman 
spectroscopy in head and neck cancer. Head & neck 
oncology, 2(1), 1-6. 

Hashim, D., Genden, E., Posner, M., Hashibe, M., & 
Boffetta, P. (2019). Head and neck cancer prevention: 
from primary prevention to impact of  clinicians on 
reducing burden. Annals of  Oncology, 30(5), 744-756. 

Ibrahim, O. R., Lugga, A. S., Ibrahim, N., Aladesua, O., 
Ibrahim, L. M., Suleiman, B. A., & Suleiman, B. M. 
(2021). Impact of  climatic variables on childhood 
severe malaria in a tertiary health facility in northern 
Nigeria. Sudanese Journal of  Paediatrics, 21(2), 173. 

Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. 
Y., Bauman, J. E., & Grandis, J. R. (2020). Head and 
neck squamous cell carcinoma. Nature reviews Disease 
primers, 6(1), 92. 

Joko‐Fru, W. Y., Jedy‐Agba, E., Korir, A., Ogunbiyi, 
O., Dzamalala, C. P., Chokunonga, E., Wabinga, H., 
Manraj, S., Finesse, A., & Somdyala, N. (2020). The 
evolving epidemic of  breast cancer in sub‐Saharan 
Africa: Results from the African Cancer Registry 



Pa
ge

 
43

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 2(2) 36-43, 2023

Network. International Journal of  Cancer, 147(8), 2131-
2141. 

Jou, A., & Hess, J. (2017). Epidemiology and molecular 
biology of  head and neck cancer. Oncology research and 
treatment, 40(6), 328-332. 

Kong, L., & Birkeland, A. C. (2021). Liquid biopsies 
in head and neck cancer: current state and future 
challenges. Cancers, 13(8), 1874. 

Lalla, R. V., Brennan, M. T., Gordon, S. M., Sonis, S. 
T., Rosenthal, D. I., & Keefe, D. M. (2019). Oral 
mucositis due to high-dose chemotherapy and/or 
head and neck radiation therapy. JNCI Monographs, 
2019(53), lgz011.

Liao, L.-J., Lo, W.-C., Hsu, W.-L., Wang, C.-T., & Lai, M.-S. 
(2012). Detection of  cervical lymph node metastasis 
in head and neck cancer patients with clinically N0 
neck—a meta-analysis comparing different imaging 
modalities. BMC cancer, 12, 1-7. 

Mady, L. J., Kubik, M. W., Baddour, K., Snyderman, C. H., 
& Rowan, N. R. (2020). Consideration of  povidone-
iodine as a public health intervention for COVID-19: 
Utilization as “Personal Protective Equipment” for 
frontline providers exposed in high-risk head and 
neck and skull base oncology care. Oral oncology, 105, 
104724.

Mody, M. D., Rocco, J. W., Yom, S. S., Haddad, R. I., & 
Saba, N. F. (2021). Head and neck cancer. The Lancet, 
398(10318), 2289-2299.

Mosalleum, E. (2014). Epidemiology of  oral malignancies 
in the Sudan. 

Msyamboza, K. P., Dzamalala, C., Mdokwe, C., Kamiza, 
S., Lemerani, M., Dzowela, T., & Kathyola, D. (2012). 
Burden of  cancer in Malawi; common types, incidence 
and trends: national population-based cancer registry. 
BMC research notes, 5, 1-8. 

Pai, S. I., & Westra, W. H. (2009). Molecular pathology 
of  head and neck cancer: implications for diagnosis, 
prognosis, and treatment. Annual Review of  Pathology: 
Mechanisms of  Disease, 4, 49-70. 

Papillomaviruses, H. (2011). IARC monographs on the 
evaluation of  carcinogenic risks to humans. Lyon, 
France: IARC. 

Perri, F., Ionna, F., Longo, F., Scarpati, G. D. V., De 
Angelis, C., Ottaiano, A., Botti, G., & Caponigro, 
F. (2020). Immune response against head and neck 
cancer: biological mechanisms and implication on 
therapy. Translational Oncology, 13(2), 262-274. 

Peter, F., Wittekindt, C., Finkensieper, M., Kiehntopf, M., 
& Guntinas-Lichius, O. (2013). Prognostic impact of  
pretherapeutic laboratory values in head and neck 
cancer patients. Journal of  cancer research and clinical 
oncology, 139, 171-178. 

Ritchie, A. I., & Singanayagam, A. (2020). Immunosuppression 
or hyperinflammation in COVID-19: a double-edged 

sword. Lancet, 395(10230), 1111. 
Russell, M. L. (2015). Nursing Implications of  Radiation 

Therapy. Core Curriculum for Oncology Nursing-E-
Book, 226. 

Sabatini, M. E., & Chiocca, S. (2020). Human 
papillomavirus as a driver of  head and neck cancers. 
British journal of  cancer, 122(3), 306-314. 

Saunders, G. R., Wang, X., Chen, F., Jang, S.-K., Liu, 
M., Wang, C., Gao, S., Jiang, Y., Khunsriraksakul, 
C., & Otto, J. M. (2022). Genetic diversity fuels 
gene discovery for tobacco and alcohol use. Nature, 
612(7941), 720-724. 

Scott, A. M., Gunawardana, D. H., Bartholomeusz, 
D., Ramshaw, J. E., & Lin, P. (2008). PET changes 
management and improves prognostic stratification 
in patients with head and neck cancer: results of  a 
multicenter prospective study. Journal of  Nuclear 
Medicine, 49(10), 1593-1600. 

Starzyńska, A., Sobocki, B. K., & Alterio, D. (2022). 
Current Challenges in Head and Neck Cancer 
Management. In Multidisciplinary Digital Publishing 
Institute, 14, 358.

Syrigos, K. N., Karachalios, D., Karapanagiotou, E. M., 
Nutting, C. M., Manolopoulos, L., & Harrington, 
K. J. (2009). Head and neck cancer in the elderly: an 
overview on the treatment modalities. Cancer treatment 
reviews, 35(3), 237-245. 

Turbeville, H. R., Toni, T. A., & Allen, C. (2022). Immune 
Landscape and Role of  Immunotherapy in Treatment 
of  HPV-Associated Head and Neck Squamous Cell 
Carcinoma (HNSCC). Current Otorhinolaryngology 
Reports, 10(1), 96-107.

Van Leeuwen, M. T., Grulich, A. E., McDonald, S. P., 
McCredie, M. R., Amin, J., Stewart, J. H., Webster, 
A. C., Chapman, J. R., & Vajdic, C. M. (2009). 
Immunosuppression and other risk factors for lip 
cancer after kidney transplantation. Cancer epidemiology, 
biomarkers & prevention, 18(2), 561-569. 

Wright, S. (2023). Flowchart. Care of  Head and Neck 
Cancer Patients for Dental Hygienists and Dental 
Therapists, 53-53. 

Zaryouh, H., Vara-Messler, M., Vignau, J., Machiels, J.-
P., Wouters, A., Schmitz, S., & Corbet, C. (2022). 
Microenvironment-driven intratumoral heterogeneity 
in head and neck cancers: clinical challenges and 
opportunities for precision medicine. Drug Resistance 
Updates, 100806. 

Zhou, L., Mudianto, T., Ma, X., Riley, R., & Uppaluri, 
R. (2020). Targeting EZH2 Enhances Antigen 
Presentation, Antitumor Immunity, and Circumvents 
Anti–PD-1 Resistance in Head and Neck 
CancerEZH2 Is a Negative Regulator of  HNSCC 
Antigen Presentation. Clinical Cancer Research, 26(1), 
290-300. 


